Advancing SilverSil sol-gel chemistry towards practical application

G. Li Petri, R. Ciriminna, M. Pagliaro

ChemistrySelect, vol. 10(4), 2025, pp. e202404287

Antibacterial Activity of Textiles Functionalized with SilverSil

ChemRxiv, --, 2025, pp. --

Citrus Flavonoids as Antimicrobials

Chemistry & Biodiversity, vol. 23, 2025, pp. e202403210

Citrus IntegroPectin: a computational insight

Discover Molecules, vol. 3, 2025, pp. -

Citrus IntegroPectin: a multifunctional bioactive phytocomplex with large therapeutic potential

ChemRxiv, 2025

In vitro Activity of Citrus IntegroPectin against Lung Cancer Cells

bioRxiv, --, 2025, pp. --

Open and impactful academic publishing

Frontiers in Research Metrics and Analytics, vol. 10, 2025, pp. -

Tannin: An Insight into its Cosmeceutical Properties and Uses

ResearchGate, --, 2025, pp. --

Cavitation as a zero-waste circular economy process to convert citrus processing waste into biopolymers in high demand

R. Ciriminna, G. Angellotti, G. Li Petri, F. Meneguzzo, C. Riccucci, G. Di Carlo, M. Pagliaro

Journal of Bioresources and Bioproducts, vol. 9(4), 2024, pp. 486-494

Chestnut Tannin: New Use, Research and Bioeconomy

R. Ciriminna, F. Meneguzzo, G. Li Petri, C. Meneguzzo, G. Angellotti, M. Pagliaro

Journal of Bioresources and Bioproducts, vol. 9(3), 2024, pp. 246-252

Citrus IntegroPectin: a computational insight

V. Butera, R. Ciriminna, C. Valenza, G. Li Petri, G. Angellotti, G. Barone, F. Meneguzzo, V. Di Liberto, A. Bonura, M. Pagliaro

ChemRxiv, 2024

Citrus wastewater as a source of value-added products: Quali-quantitative analysis and in vitro screening on breast cancer cell lines

M. V. Raimondi, S. Rigogliuso, F. Saiano, P. Poma, M. Labbozzetta, M. Barreca, M. Barbera, R. Bivacqua, G. Li Petri, S. Buscemi, I. Sardo, V. Spanò, A. Palumbo Piccionello, A. Montalbano, P. Barraja, M. Notarbartolo

Archiv der Pharmazie, vol. 357(12), 2024, pp. e2400530

CytroCell@ PIL: a new Citrus nanocellulose-polymeric ionic liquid composite for enhanced anion exchange membrane alkaline water electrolysis

E. Fontananova, R. Ciriminna, D. Talarico, F. Galiano, A. Figoli, G. Di Profio, R. Mancuso, B. Gabriele, G. Angellotti, G. Li Petri, F. Meneguzzo, M. Pagliaro

ChemRxiv, 2024

Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3/4A Peptidomimetic Inhibitors. What Did We Learn?

S. Di Martino, G. Li Petri, M. De Rosa

Journal of Medicinal Chemistry, vol. 67(2), 2024, pp. 885-921

Nanocellulose and microcrystalline cellulose from citrus processing waste: a review

R. Ciriminna, G. Li Petri, G. Angellotti, E. Fontananova, R. Luque, M. Pagliaro

International Journal of Biological Macromolecules, vol. 281, 2024, p. 135865

Reproducibility in chemistry research

R. Ciriminna, G. Angellotti, G. Li Petri, M. Pagliaro

Heliyon, vol. 10(14), 2024, pp. e33658

Editorial: Emerging heterocycles as bioactive compounds

G. Li Petri, R.Holl, V. Spanò, M. Barreca, I. Sardo, M. V. Raimondi

Frontiers in Chemistry, 2023

Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis.

M. Barreca, M. Buttacavoli, G. Di Cara, C. D’amico, E. Peri, V. Spanò, G. Li Petri, P. Barraja, M. V. Raimondi, P. Cancemi, A. Montalbano

European Journal of Medicinal Chemistry, 2023

Peptidomimetics: An Overview of Recent Medicinal Chemistry Efforts toward the Discovery of Novel Small Molecule Inhibitors.

G. Li Petri, S. Di Martino, M. De Rosa

Journal of Medicinal Chemistry, 2022

Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds

G. Li Petri, M. V. Raimondi, V. Spanò, R. Holl, P. Barraja, A. Montalbano

Topics in current chemistry, 2021

THE KEY ROLE OF THE CLINICAL PHARMACIST IN THE MANAGEMENT OF ANTICANCER THERAPIES: A PILOT STUDY IN THE TREATMENT OF PATIENTS WITH NON SMALL CELL LUNG CANCER

M. Barreca, V. Spano, M. V. Raimondi, G. Li Petri (corresponding author), P. Marrone, P. Amari, L. Blasi

Pharmacologyonline, 2021

3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma

S. Cascioferro, G. Li Petri (co-first author), B. Parrino, B. El Hassouni, D. Carbone, V. Arizza, U.Perricone, A. Padova, N. Funel, G. Peters, G. Cirrincione, E. Giovannetti, P. Diana

Molecules, 2020

Bioactive pyrrole-based compounds with target selectivity

G. Li Petri, V. Spanò, R. Spatola, R. Holl, M. V. Raimondi, P. Barraja, A. Montalbano

European Journal of Medicinal Chemistry, 2020

Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells

S. Cascioferro, G. Li Petri (co-first author), B. Parrino, D. Carbone, N. Funel, C. Bergonzini, G. Mantini, H. Dekker, D. Geerke, G. Peters, G. Cirrincione, E. Giovannetti, P. Diana

European journal of medicinal chemistry, 2020

Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds

G. Li Petri, B. El Hassouni, R. Sciarrillo, N. Funel, G. Mantini, E. A. Zeeuw van der Laan, S. Cascioferro, A. Avan, P. Zucali, N. Zaffaroni, T. Lagerweij, B. Parrino, K. Smid, M. Deraco, C. Granchi, A. Braczko, R. Smoleński, L. Matherly, G. Jansen, Y. Assaraf, P. Diana, J. Cloos, G. Peters, F. Minutolo, E. Giovannetti

British Journal of Cancer, 2020

New Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives Inhibit FAK Phosphorylation and Potentiate the Antiproliferative Effects of Gemcitabine Through Modulation of the Human Equilibrative Nucleoside Transporter-1 in Peritoneal Mesothelioma

G. Li Petri, C. Pecoraro, O. Randazzo, S. Zoppi, S. Cascioferro, B. Parrino, D. Carbone, B. El Hassouni, A. Cavazzoni, N. Zaffaroni, G. Cirrincione, P. Diana, G. Peters, E. Giovannetti

Anticancer Research, 2020

New Synthetic Nitro-Pyrrolomycins as Promising Antibacterial and Anticancer Agents

M. V. Raimondi, A. Presentato, G. Li Petri (corresponding author), M. Buttacavoli, A. Ribaudo, V. De Caro, R. Alduina, P. Cancemi

Antibiotics, 2020

2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent staphylococcal biofilm inhibitors.

S. Cascioferro, B. Parrino, G. Li Petri, M. Cusimano, D. Schillaci, V. Di Sarno, S. Musella, E. Giovannetti, G. Cirrincione, P. Diana

European journal of medicinal chemistry, 2019

A Brief Guide to Performing Pharmacological Studies In Vitro: Reflections from the EORTC-PAMM Course “Preclinical and Early-phase Clinical Pharmacology”

M. Capula, C. Corno, B. El Hassouni, G. Li Petri, S. Aranđelović

Anticancer Research, 2019

Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)-1H-indole Derivatives Against Pancreatic Cancer Cells

G. Li Petri, S. Cascioferro, B. El Hassouni, D. Carbone, B. Parrino, G. Cirrincione, G. J. Peters, P. Diana, E. Giovannetti

Anticancer Research, 2019

Pharmacogenetics of treatments for pancreatic cancer

B.El Hassouni, G. Li Petri, D. S. K. Liu, S. Cascioferro, B.Parrino, W. Hassan, P. Diana, A. Ali, A. E. Frampton, E. Giovannetti

Expert Opinion on Drug Metabolism and Toxicology, 2019

To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology

B. El Hassouni, G. Mantini, G. Li Petri, M. Capula, L. Boyd, H. N. W. Weinstein, A. Vallés-Martí, M. Kouwenhoven, E. Giovannetti, B. Westerman, G. Peters

Anticancer Research, 2019

Proton-coupled folate transporter as a biomarker of outcome to treatment for pleural mesothelioma.

G. Li Petri, S. Cascioferro, B. Parrino, G. Peters, P. Diana, E. Giovannetti

Pharmacogenomics (London), 2018